- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes and lipid metabolism
Authors
Keywords
Diabetes mellitus, Lipid metabolism, Diabetic dyslipidemia, Epidemiology, Pathophysiology, Treatment, Residual cardiovascular risk
Journal
Hormones-International Journal of Endocrinology and Metabolism
Volume 17, Issue 1, Pages 61-67
Publisher
Springer Nature
Online
2018-04-30
DOI
10.1007/s42000-018-0014-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes
- (2017) Tuba Bulut et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
- (2017) Donald M. Lloyd-Jones et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors: Shaping the future after the further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk (FOURIER) trial
- (2017) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
- (2017) Vasilios G. Athyros et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 Fatty Acids and Cardiovascular Disease: Summary of the 2016 Agency of Healthcare Research and Quality Evidence Review
- (2017) Ethan Balk et al. Nutrients
- Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes
- (2017) Maryam Khavandi et al. Current Cardiology Reports
- Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia
- (2016) Andrew W. Dake et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. ATHEROSCLEROSIS
- 9. Cardiovascular Disease and Risk Management
- (2016) DIABETES CARE
- Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes
- (2016) Georgina M. Williams et al. DIABETOLOGIA
- Effect of micronized fenofibrate on microvascular complications of type 2 diabetes: a systematic review
- (2016) Leszek Czupryniak et al. EXPERT OPINION ON PHARMACOTHERAPY
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Variable effects of statins on glucose homeostasis parameters and their diabetogenic role
- (2015) Michael S. Kostapanos et al. DIABETOLOGIA
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intestinal Lipid Handling
- (2014) Alain Veilleux et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New and emerging regulators of intestinal lipoprotein secretion
- (2014) Changting Xiao et al. ATHEROSCLEROSIS
- Postprandial hypertriglyceridemia as a coronary risk factor
- (2014) Jan Borén et al. CLINICA CHIMICA ACTA
- Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors
- (2014) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
- (2014) Claudia Stefanutti et al. CURRENT PHARMACEUTICAL DESIGN
- 8. Cardiovascular Disease and Risk Management
- (2014) DIABETES CARE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
- (2013) Stanley Ip ANNALS OF INTERNAL MEDICINE
- Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations
- (2013) Unjali P. Gujral et al. Annals of the New York Academy of Sciences
- Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2013) Amirhossein Sahebkar et al. ATHEROSCLEROSIS
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Statin–fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low
- (2013) Vasilios G. Athyros et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of ezetimibe on atherogenic lipoproteins and glucose metabolism in patients with diabetes and glucose intolerance
- (2013) Tetsuji Tsunoda et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Global estimates of diabetes prevalence for 2013 and projections for 2035
- (2013) L. Guariguata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men
- (2013) J. Wang et al. JOURNAL OF INTERNAL MEDICINE
- Diabetes: a 21st century challenge
- (2013) Paul Z Zimmet et al. Lancet Diabetes & Endocrinology
- Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis
- (2012) Marcello Arca et al. Current Vascular Pharmacology
- Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis
- (2012) A. E. Long et al. DIABETES
- GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion
- (2012) J. Doucet et al. DIABETES & METABOLISM
- Clinical benefits of ezetimibe use: is absence of proof, proof of absence?
- (2012) Ioanna Gouni-Berthold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Role of the Gut in Lipid Homeostasis
- (2012) Nada A. Abumrad et al. PHYSIOLOGICAL REVIEWS
- Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
- (2012) Alexander Tenenbaum et al. PLoS One
- Thinking Beyond Traditional Cardiovascular Risk Factors
- (2011) Niki Katsiki et al. ANGIOLOGY
- ESC/EAS Guidelines for the management of dyslipidaemias
- (2011) Alberico L. Catapano et al. ATHEROSCLEROSIS
- News from the literature: Focus on joint ESC/EAS dyslipidemia guidelines
- (2011) Jane Stock ATHEROSCLEROSIS
- Regulation of chylomicron production in humans
- (2011) Changting Xiao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary
- (2011) Dimitri P. Mikhailidis et al. Current Vascular Pharmacology
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Remnant Lipoproteins As Strong Key Particles to Atherogenesis
- (2011) Yoshio Fujioka et al. Journal of Atherosclerosis and Thrombosis
- Treatment of dyslipidemia in patients with type 2 diabetes
- (2011) Krishnaswami Vijayaraghavan Lipids in Health and Disease
- Costos de la Diabetes en Ameŕica Latina: Evidencias del Caso Mexicano
- (2011) Armando Arredondo et al. VALUE IN HEALTH
- "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study
- (2010) Alexander Tenenbaum et al. Cardiovascular Diabetology
- Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
- (2010) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
- (2010) Kiran Musunuru LIPIDS
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
- (2009) Konstantinos Tziomalos et al. CURRENT DRUG TARGETS
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials
- (2008) John A. Farmer Current Diabetes Reports
- The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
- (2008) Jean-Charles Fruchart et al. Diabetes & Vascular Disease Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started